At least 30 dogs in England have been killed in less than 18 months by an unknown disease which causes skin lesions and kidney failure, reveals research published in Veterinary Record.

Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment, has announced study results demonstrating that its DecisionDx-Melanoma™ gene expression profile...

For the first time, Boehringer Ingelheim announced Phase II data from its investigational compound BI 655066*.

Celgene Corporation has announced that results from its ongoing phase III LIBERATE trial evaluating Otezla® (apremilast), the Company's oral, selective inhibitor of phosphodiesterase 4 (PDE4)...

Sebacia, Inc., a company dedicated to delivering breakthrough treatments to advance dermatology, has announced new research showing that selective targeting of sebaceous glands using the Sebacia...

Galderma Laboratories, L.P. has announced positive phase 3 trial results of adapalene 0.3%/benzoyl peroxide 2.5% (0.

Acne, a scourge of adolescence, may be about to meet its ultra high-tech match.

Researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have found that two common antibiotic treatments work equally well...

Dermatologist-prescribed treatments are being left on pharmacy shelves by up to a quarter of people with acne, according to a new study.

Results of a new study by UCLA researchers has found that a new triple combination drug therapy shows promising signs of more effectively controlling advanced melanoma than previous BRAF + MEK...